Neoplasia/BPH

	Uretero-enteric strictures after cystectomy: revealing the modifiable risk factors. Can J Urol Akkad A, Bruyere F, Bourgi A. PMID: 41800511 [PubMed - indexed for MEDLINE]
	Artificial intelligence assisted 3D in the robotic urooncology? A systematic review and narrative synthesis of current applications, challenges and future directions. Can J Urol Barakat B, Al-Absi B, Hadaschik B, Rehme C, Schakaki S, Bauer J. PMID: 41800506 [PubMed - indexed for MEDLINE]
	Oncological outcomes of I125low dose brachytherapy in localized prostate cancer. Can J Urol Chéchile Toniolo G, Jornet N, Rojas J, Tejedor N, Carrara S, Maccagno A, Brufau T. PMID: 41800505 [PubMed - indexed for MEDLINE]
	PSMA PET/CT-guided pelvic lymph node dissection in patients with unfavorable intermediate- or high-risk prostate cancer. Can J Urol Donck E, Verbeke S, De Visschere P, Fonteyne V, Van Praet C, De Man K, Lumen N. PMID: 41800504 [PubMed - indexed for MEDLINE]
	Suprapubic transvesical adenoma resection of the prostate (STAR-P): step-by-step technique. Can J Urol Gozzi C, Bucca B, Dalpiaz O, Brassetti A, Gobbi LM, Basile G, Djordjevic M. PMID: 41800503 [PubMed - indexed for MEDLINE]
	Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects. Can J Urol Zhan M, Zhou Z, Zhang J, Wang X, Li C, Pan B, Luo Z, Shi W, Wang Y, Li M, Wang W, Shi R, Zhu J. PMID: 41800500 [PubMed - indexed for MEDLINE]
	Prostate specific membrane antigen (PSMA) as a biomarker in early and localized advanced prostate cancer: a narrative review. Can J Urol Carll J, Bonaddio J, Woon D, Perera M, Lawrentschuk N, Chengodu T. PMID: 41800499 [PubMed - indexed for MEDLINE]
	Association between periodontal disease and prostatic disease: a systematic review and meta-analysis of observational studies. Can J Urol Li Q, Wu L, Zhang Y, Huang D, Ou-Yang S, Yang JY, Li BH, Zeng XT. PMID: 41800498 [PubMed - indexed for MEDLINE]
	Renal cell carcinoma incidence and mortality in California: a population-based study of sociodemographic patterns and temporal trends from 1988 through 2019. Lancet Reg Health Am L'Espérance K, Lin K, Lichtensztajn D, Christoph Soerensen SJ, Gulati S, Deng Z, Leppert JT, Oh DY, Sakoda LC, Washington SL 3rd, Meng MV, Chan JM, Langston ME, Cheng I, Chung BI, Graff RE. PMID: 41800233 [PubMed]
	Correction: Preoperative inflammation-based immune prognostic nomogram in bladder cancer: a multicenter study. Front Oncol Feng R, Zhang J, Tao Y, Hou J, Tai W. PMID: 41800054 [PubMed]
	Patients' knowledge, attitudes, preferences regarding kidney cancer screening, and factors influencing participation intentions: a qualitative study. Front Oncol Ma X, Liu R, Zhuo H, Xi X. PMID: 41800044 [PubMed]
	Impact of Renin-Angiotensin System Inhibitors on Renal Function During Temporary Ileostomy Period in Rectal Cancer Patients: A Retrospective Cohort Study. Ann Gastroenterol Surg Shogen Y, Seishima R, Monno M, Morita S, Shigeta K, Okabayashi K, Kitagawa Y. PMID: 41799603 [PubMed]
	Standardized care pathway reshaped the diagnostic and therapeutic landscape of urinary bladder cancer. A 15-year population-based study. BJUI Compass Istamulov M, Eriksson H, Abuhasanein S. PMID: 41799330 [PubMed]
	PSMA-targeted fluorescent probe for NIR-II imaging in prostate cancer intraoperative navigation and tumor margin mapping. Theranostics Jiang Z, Tan H, Wu B, Zhang L, Kadeerhan G, Zhang J, Jin J, Zhang Z, Guo H, Guo W, Jia J, Tian J, Tang BZ, Wang D. PMID: 41799210 [PubMed - indexed for MEDLINE]
	Specific in vivo detection of V2R-positive metastatic ccRCC using a toxin-based PET radioligand. Theranostics Petrovic GS, Chmeis K, Gonand A, Leguerney I, Ingels A, Kereselidze D, Jego B, Denis C, Urman A, Chaigneau M, Baudat R, Guyot A, Kessler P, Keck M, Servent D, Richard M, Gilles N, Truillet C. PMID: 41799197 [PubMed - indexed for MEDLINE]
	Role of miRNA in diagnosis of Wilms tumor and neuroblastoma. Indian J Cancer Kakkar D, Mallick S, Ahmad A, Goswami A, Agarwala S, Gupta AK, Bakhshi S, Devasenathipathy K, Mathur S, Prasad J, Jain D, Seth R, Iyer VK. PMID: 41797588 [PubMed - indexed for MEDLINE]
	Clinical significance of volumetric 68Ga-prostate-specific membrane antigen PET/computed tomography parameters in prostate cancer staging. Nucl Med Commun Okar Y, Yel H. PMID: 41797573 [PubMed - as supplied by publisher]
	Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents. Cancer Wang TF, Clarke A, Rath M, Yoo S, Fremont D, Wu C, Ravani P, Bossé D, Talarico R, Carrier M, Sood MM. PMID: 41797435 [PubMed - indexed for MEDLINE]
	Research Progress on Financial Toxicity in Bladder Cancer Patients. J Surg Oncol Mengyan J, Jun Q, Wen L, Tingting P, Liyuan W. PMID: 41797296 [PubMed - as supplied by publisher]
	The Safety and Effectiveness of Hypofractionated Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-analysis. Crit Rev Oncol Hematol Mo C, Chen C, Fan L, Li J, Fan N, Ding H. PMID: 41796913 [PubMed - as supplied by publisher]

Articles 1 - 20 / 186123

Page 1 of 9307



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy